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Infection  of  the  mouse  peritoneal  cavity  by  bacillus  Calmette-Gu6rin  (BCG) 1 
markedly  alters  the  surface  properties  of macrophages  (mob), compard  with  cells 
obtained  from uninfected  control animals or after injection  of thioglycollate broth. 
BCG-activated  peritoneal  mob  (BCG-PM)  express  enhanced  Ia  antigens  (Ag),  but 
reduced receptors for mannose-terminated glycoconjugates (MFR), Fc receptors, and 
m@speeific surface Ag F4/80  (1).  Decreased receptor-mediated endocytosis is associ- 
ated with active secretion of plasminogen activator (PA)  (2), the ability to release 02- 
and  H202  after  surface  stimulation  (3,  4),  and  enhanced  activity  against  various 
organisms and target cells (5, 6). The increase in Ia Ag (7-9)  and in secretory (2,  10) 
and anti-microbial activity (11,  12)  can depend on specifically sensitized T  lympho- 
cytes, and some of these effects are induced in nonactivated macrophages by treatment 
with lymphokines. 
Surface antigens  and receptors control recognition and effector functions of acti- 
vated  m¢  and  provide  ideal  markers  to  study  the  complex  effects of lymphocyte 
products on macrophages.  We show here that  down-regulation  of mannose-specific 
endocytosis  and  Ag  F4/80  accompanies  induction  of mq~  Ia  by  Ag-stimulated  T 
lymphocytes and lymphokines.  These alterations  in  the plasma membrane make it 
possible to distinguish between activated and nonactivated macrophages and permit 
study of the mechanism of cell activation in vitro. 
Materials and Methods 
Animals.  CBAT6T6 (H-2K) mice were bred at the Sir William Dunn School of Pathology, 
and both sexes used weighed 20-30 g. CBA nude mice were obtained from Olac Laboratories, 
Bicester, Oxon, England. 
Media and Reagents.  Iscove's modification of Dulbecco's medium (IM) was obtained from 
Gibco-Biocuh Ltd.,  Paisley,  Scotland.  Fetal  bovine serum  (FBS) from the same source was 
routinely  heat  inactivated  (56°C  for 30  min)  before use.  100 ~g/ml kanamycin, 50 #g/ml 
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1 Abbreviations used in this paper." Ab, antibody; Ag, antigen; ATDS, acid-treated dog serum; BCG, bacillus 
Calmette-Gu6rin; Con A, eoncanavalin A; FBS, fetal bovine  serum; FoR, Fc receptor; IM, Iscove's  modified 
medium; MDP, N-acetylmuramyl-L-alanyl-D-isoglutamine.  2H~O; MFR, mannosyl, fucosyl receptor; m~, 
macrophage; O2-, superoxide anion; PA, plasminogen activator; PBS, phosphate-buffered saline; PM, 
peritoneal m~b; PMA, phorbol myristate acetate; PPD, purified protein derivative; RAR, rabbit-anti-rat 
Fab; RPM, resident peritoneal m@; TPM, thioglycollate-elicited  PM. 
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streptomycin, and 50/~g/ml penicillin were added to media. Phosphate-buffered saline (PBS) 
was obtained from Oxoid Ltd., Basingstoke,  England and routinely used without calcium or 
magnesium except  for  assays  of mannose-specific endocytosis when calcium  (1.2 mM)  and 
magnesium (1.2 mM) were added.  LPS from Salmonella abortus equi, prepared by the phenol 
extraction procedure,  was  a  gift  from  Dr.  M.-L.  Lohmann-Matthes, Max  Planck Institut, 
Freiburg, (Federal  Republic of Germany). N-acetylmuramyl-L-alanyl-o-isoglutamine.  2HeO 
(MDP) was bought from Calbiochem-Behring  Corp., American Hoechst Corp., San Diego, CA, 
and Corynebacterium parvum obtained as  a  formol-killed suspension from  Dr. James  Howard, 
Wellcome Reagents Ltd.,  Beckenham, England. Thioglycollate broth and proteose peptone 
were bought from Difco Laboratories, Detroit, MI. 
Ligands.  A glycoconjugate of mannose-bovine  serum albumin (mannose-BSA) with 33-37 
mol of sugar/mol protein was a gift from Dr. P. Stahl, Washin§ton University, St. Louis, MO. 
This material was trace labeled with x2sI (1) and used at 4 ×  10  cpm/p.g.  Mannan from bakers 
yeast (M-7504;  Sigma Chemical Co., St.  Louis, MO) was used at a concentration between 5 
and 10 mg/ml to measure specific uptake of this ligand (1). 
Antibodies.  OX6, a monoclonal mouse anti-Ia K,S antibody (Ab) (13) was a generous gift of 
Dr. A. F. Williams, University  of Oxford. F4/80, a rat monoclonal Ab specific for mature mouse 
md~, was used as a concentrated supernatant (14). The rat anti-mouse Fc receptor antibody, 
2.4G2 (15), produced by Dr. J. Unkeless, The Rockefeller University, New York was used as a 
concentrated supernatant. Mac-I/70 (16), which binds to m~b and polymorphonuclear leuko- 
cytes, was obtained from Dr. T. Springer, Harvard Medical School,  Boston, MA, and used as 
a concentrated supernatant. An affinity-purified  F(ab')2 fragment of rabbit anti-rat Fab (RAR) 
was trace-labeled for indirect binding assays. This reagent cross-reacts  with mouse immuno- 
globulin (Ig). A rat anti-Thy-1 (monomorphic) cytotoxic antibody (YBM 29.2.1) was obtained 
as an ascites fluid from Dr. H. Waldmann, Department of Pathology, Cambridge, England. 
Peritoneal Cells.  Resident peritoneal m4~ (RPM) were obtained from untreated animals, and 
elicited m~b obtained 4 d after intraperitoneal injection  of thioglycollate-broth (1 ml), endotoxin 
(30 #g), MDP (200/xg), or proteose  peptone (1 ml of 1% solution). BCG-PM were obtained 8- 
21 d after intraperitoneal infection with -  1 X 107 live organisms, Pasteur strain 1011, obtained 
from Dr.  R. North, Trudeau Institute, Saranac Lake,  NY  (1). C. parvum-activated  PM were 
obtained 14 d after intraperitoneal injection of 0.2 ml of PBS containing 1.4 mg dry weight of 
organisms. 
Peritoneal cells were washed, resuspended in medium (IM +  5% FBS), and plated in 24- or 
96-well tissue culture trays (Linbro Chemical Co., Flow Laboratories, Irvine, Scotland) at 5 x 
105  or  1 X  105  mff/well, respectively.  The  number of mqb in the  peritoneal washouts  was 
determined in a haemocytometer after staining with Turk's solution. Adherent cell monolayers 
(>95%  F4/80 positive)  will be referred  to as m~b and were  used in various assays  after 4 h 
incubation at  37°C or after cultivation for  up to  5 d  in IM +  5%  FBS.  Cell viability was 
estimated by trypan blue dye exclusion, phase-contrast microscopy, and lysozyme production. 
Adherent cells from all preparations showed  >95% viability by these criteria. The recovery of 
adherent cells was estimated after lysis with 1 N NaOH and cell protein analysis by the method 
of Lowry et al.  (17). 
Nylon Wool Separation of Lymphoc~tes.  BCG-primed peritoneal cells were incubated in IM + 
5% FBS for 2 h at 37°C, 5 ×  10  cells/100-mm tissue  culture dish (Falcon Labware, Div. of 
Becton, Dickinson & Co.,  Oxnard, CA).  The nonadherent cells were removed by two gentle 
washes of the adherent monolayer. Cells were collected by centrifugation and resuspended in 
2 ml IM +  5% FBS and overlayed on a nylon-wool column (500 mg; Fenwal Inc., Ashland, 
MA), which had been preincubated with IM +  10% FBS for 30 min at 37°C (18). The column 
with cells was incubated at 37°C for 30 rain and the nonadherent cells eluted with IM at 37°C. 
The  cells  were  then  washed,  counted,  suspended  in  IM  +  5%  FBS,  and  either  injected 
intraperitoneally into mice at  1-5  X  105 in 0.2  ml saline, with or without 50/Lg  of purified 
protein derivative (PPD,  Connaught Medical  Research  Laboratories, Toronto, Canada)  or 
added to monolayers of RPM or TPM with or without 50 ~g/ml PPD. 30% of nonadherent 
cells, of which <1% were mff, were recovered after passage  over the nylon wool columns. Cell 
viability by trypan blue exclusion was >97%. 
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bated with a  1:200 dilution of anti-Thy-1 Ab at 4°C for 60 min, washed twice, incubated with 
low toxicity guinea pig complement (Sera Laboratories, Crawley) at 1 in 10 dilution for 45 min 
at 37°C, and washed twice in PBS. The 40% viable cells remaining were added to adherent 
TPM with PPD and cultivated for 2 d. 90% of the lymphocytes were viable after incubation 
with complement alone. 
Lymphokine Preparation.  Immune lymphokine was prepared from spleens removed from CBA 
mice infected 14-21 d previously with live BCG, intraperitoneally. A single-cell suspension was 
washed twice in PBS and the cells cultured in IM +  5% FBS with 50 lag/ml PPD for 72 h at 
37°C in a T-75 flask (Falcon Labware). Supernatants were centrifuged for 10 min at 450 g and 
passed  through a 0.22-~.m Millex filter (Millipore Corp., Bedford, MA). Control lymphokine 
was prepared by culturing BCG spleen cells in the absence of PPD, which was added to the 
supernatant before filtration. The immune lymphokine was stored for up to  1 wk at 4°C and 
was  active  in  the  range  8-30%  vol/vol.  10%  was  used  routinely and  fresh  medium  and 
lymphokine were added daily to cells cultivated >24 h. 
Concanavalm A (Con A) Lymphokine.  Suspensions of spleen cells from untreated animals were 
cultivated in IM +  2% FBS with 3/~g/ml Con A for 2 d (Pharmaeia Fine Chemicals, Uppsala, 
Sweden). Con A was absorbed by passing the supernatant down a Sephadex G10 column. The 
Con A lymphokine contained nondialyzable inhibitor(s) of growth, determined by [aH]thymi- 
dine incorporation, and of PA secretion by mq~. These inhibitory activities could be removed by 
concentrating the supernatant fivefold in an Amicon filtration cell across a PM-10 membrane 
(19). 
Assays of Mannose-specific Endocytosis.  This was  assayed at saturation by incubating mq~ in 
300 ~1 of IM +  5% FBS with 18/~g 125I-mannose-BSA, with or without mannan (1). After 20- 
30  min at  37°C, the cells were washed  five  times, lysed  with IN NaOH,  and radioactivity 
measured in a  Packard gamma spectrometer (Packard Instrument Co.,  Inc., Downers grove, 
IL). Results were expressed as ng mannose-BSA  specifically taken up per 5 ×  10  -5 macrophages 
plated. Nonspecific uptake was always <5% of specific uptake. 
Antigens.  Binding of monoclonal Ab to mq~, which had been fixed  for  10 min with 0.25% 
glutaraldehyde, was detected with 125I-labeled RAR. Both first- and second-stage Ab were at 
saturation, so that  the number of RAR molecules bound is proportional to the number of 
molecules of first stage Ab and thus a measure of Ag expression (14). Assays were performed at 
4°C in the presence of sodium azide. Control preparations without first Ab showed <10% of 
specific binding. Results were expressed  as the number of RAR molecules bound per mq~. 
Single Cell Analys# Ag.  Cover slip preparations of TPM and RPM were prepared after 48 
h  cultivation with immune or control lymphokine (10% vol/vol). The cover slips were then 
125  5  incubated with saturating concentrations of monoclonal Ab and  I RAR (5 ×  10  cpm/cover 
slip) and processed  for autoradiography. 
Uptake of 125I-Mannose BSA.  Similar preparations were incubated with  18 Bg/ml x25I-man- 
nose-BSA with or without mannan, for 20 rain at 37°C. Mannan-treated controls showed no 
labeling. 
Secretion Products.  PA secretion was assayed on 125I-fibrin  plates (20). Different concentrations 
of m~ (6 X  104-5 X 105/well) were euhivated 4-48 h, and plasminogen dependent fibrinolytic 
activity assayed with acid-treated dog serum (ATDS) as the source of plasminogen. Fibrinolysis 
in serum free medium was <5% of that in ATDS. Superoxide anion was assayed after addition 
of 20 ng phorbol myristate acetate (PMA, Sigma Chemical Co.)  (3, 21). Results were expressed 
as nmol 02- released/rag cell protein/60 min. Superoxide dismutase, 25/~g/ml (SOD, Sigma 
Chemical Co.)  inhibited >80% of cytochrome C  reduction. 02- production by lymphokine- 
activated mdp was assayed after 24 h treatment. Lysozyme was assayed by the lysoplate method 
(20) with chick egg lysozyme as standard. 
Results 
Effects of the Route and Time Course of BCG Infection on Macrophage Surface Properties and 
Secretion.  This  was  examined  as  a  basis  for  further  studies.  After  intraperitoneal 
infection with BCG under standard conditions, the surface, endocytic, and secretory 
properties of m~ showed highly reproducible changes compared with RPM or TPM 1626  LYMPHOCYTE PRODUCTS AND THE MACROPHAGE PLASMA MEMBRANE 
(Table I). As reported previously (1), mannose-specific endocytosis, Ag F4/80, and Fc 
receptor  Ag  2.4G2  were  reduced  to  20-50%  of control  values,  whereas  Ia  (0X  6) 
expression was increased by 250-400%.  BCG-PM released large amounts of 02- after 
PMA  stimulation,  and  also  PA,  whereas TPM  released  high  levels of PA,  but  less 
Oz-. Expression of Mac- 1 ag, not studied previously, was relatively stable and showed 
only  minor  changes  after  BCG  infection,  usually  <10%.  Comparable  surface  and 
other properties were found whether results were expressed in terms of mq~ number or 
cell protein. These changes were observed 6-42 d after BCG infection, but not 2 or 4 
d  after intraperitoneal  infection  with  twice the  standard  dose.  The effects of more 
prolonged infection were not studied.  Intravenous infection induced  the same prop- 
erties in PM and further intraperitoneal treatment of these animals with PPD or heat- 
killed BCG did not accentuate the changes (not shown). 
Role of Sensitized Lymphocytes and Antigen 
ADOPTIVE TRANSFER IN VIVO.  TO examine the role of specifically sensitised lympho- 
cytes in modulating the surface properties of macrophages, nylon wool-enriched BCG- 
primed peritoneal cells were first injected intraperitoneally into uninfected syngeneic 
mice, with or without  PPD.  PM harvested 48 h  after injection of sensitized lympho- 
cytes with  PPD showed  a  similar pattern  of surface changes and  secretion  to BCG 
infection  (Table  1 and Fig.  1).  Specific uptake of lzSI-mannose-BSA was reduced by 
55-60% and Ag F4/80 to a lesser extent, by 35-50%, whereas Ia Ag and secretion of 
PA and O2- were enhanced  2-4-fold relative to mock-injected or untreated controls. 
Injection of sensitized lymphocytes without  PPD failed to induce any change in the 
PM, whereas PPD alone contributed up to one-third to the increase in Ia. PPD alone 
decreased mannose-specific endocytosis by 40%, but did not diminish Ag F4/80. The 
effective range  of lymphocytes was  1-10  ×  105  per  animal,  the  minimal  effective 
concentration of PPD 25-50/lg. 
We concluded that adoptive transfer of sensitized lymphocytes with specific antigen 
was able to induce the complete activation phenotype in PM from uninfected animals, 
but  less efficiently than  infection with BCG for markers such as Ag F4/80.  PPD by 
itself had an intermediate effect which will be discussed further below. 
TABLE I 
Macrophage Propertzes after Infection with BCG or Injection of BCG-prirned Lymphocytes Plus PPD into 
the Peritoneal Cavity * 
MFR  (rig uptake  Ag expression  (nml/mq~ X  10  *) 
of t~S[-mannose- 
Treatment  BSA/5 ×  10  5 
m4,/30 rain/  F4/80  0X 6  24(;2 
37°C) 
Release of  $  Fibrinolysis  (Pc> 
cent solubilized/ 
02  (nmol/  180 rain/2 X  105 
Mac 1  mR/60 min) 
BCG infection  25 ±  8  7:1:2  20 ±  4  8  +  I  50 ±  12  180 ±  20  55 ±  10 
Thioglycollatc broth  .90 ±  12  36 ±  6  8  ±  2  23 ±  6  60 ±  15  80 -- 30  66 --+ 5 
RPM  80±  10  51  ::1::8  4±3  14::t:5  56±  10  26±8  12±5 
BeG-sensitized [ympho-  38 ±  4  25 :k  5  15 ±  [  8  ±  4  42 _  [8  150 ±  10  60 ±  5 
cytes and  PPI) 
Mock transfer,  medium  83 ±  12  38 a: 2  8  ±  4  ND§  48 ::t: 16  34 ±  6  ~5 ±  3 
a]onc 
* Mice  were  either  infected  as described  in  Materials and  Methods  or  injected  with  5  X  I0  r,  BCG primed  lymphocyte~  with  50 ,ug  PP1) 
Peritoneal  cells were  harvested  aftra  2  &  and  adherent  m 0  assayed  after  4  h  Results  show  a  represenlalivc  experiment  mean  ±  SI),  of 
triplicate  (Ag) o3 duplicate assays. Similar results were obtained  in ,~t least three independenl  experiments 
:~ 20 ng PMA added  for 60 rain  Dimethyl su/foxide ccmtro/  had no effect. 
{} Not determined "6 
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Fro.  I.  Macrophage properties after injection of PPD, BCG-primed lymphocytes (L), or both into 
uninfected animals.  (A)  Antigen  expression. Mq~ were  harvested  2  d  after  injection  of  1  ×  106 
lymphocytes with or without 50/tg PPD, cultivated for 4 h in IM +  5% FBS, washed, and fixed in 
glutaraldehyde before assay.  1 ×  10  s m~ were plated per well and RAR used to detect binding of 
rat (anti-F4/80 and Mac-l) and mouse (anti-Ia H-2K) Ab at 8 ×  103 cpm//~g. Results of triplicate 
assays are expressed as a percentage change from controls (see Table I) injected with medium alone, 
±  SD. Similar results were obtained in three independent experiments. (B)  Specific uptake of 125I- 
mannose-BSA by mO obtained  and cultivated  for 4  h  as above.  5  ×  105  live m~b per  well  were 
incubated with 4  x  106 cpm/~g [igand with or without mannan, 10 mg/wel[. Results show mean 
±  SD  of pooled  results of three  independent  experiments.  (C)  Fibrinolytic  activity.  Mq5  were 
incubated with 5% vol/vol acid-treated dog serum after cultivation for 4 h in IM +  5% FBS. Results 
show  average  ±  SD  of duplicate  assays for  one  of three  similar  experiments.  (D)  Release  of 
superoxide after 60-min incubation with PMA, 20 ng/well. Results show average +  SD of duplicate 
assays for one of three similar experiments. 
CO-CULTIVATION OF  MACROPHAGES  WITH LYMPHOCYTES  AND ANTIGEN.  To  study the 
role of antigen  and  lymphocytes more  directly,  m~b from uninfected  animals were 
next exposed in culture to BCG-sensitized lymphocytes with or without PPD for 2 d 
before assay.  Untreated  and  thioglycollate-elicited  macrophages were compared as 
targets  to  evaluate  the  response  of resident  and  newly  recruited  cell  populations. 
Results are shown in Table I1 and Fig. 2. These indicate that the differences between 
BCG-activated mff and nonactivated RPM and TPM remained stable after cultiva- 
tion for 2 d (cf. Tables I and II), that BCG-sensitized lymphocytes plus PPD efficiently 1628  LYMPHOCYTE  PRODUCTS  AND  THE  MACROPHAGE PLASMA  MEMBRANE 
TASLE II 
Macrophage Properties after Addition of Sensitized Lymphocytes, Antzgen, and Lymphokine in Culture 
MFR (rig  Ag number 
Treatment  uptake/5 X 10  -5  Superoxide 
mq~/30 min 37°C)  F4/80  0X 6  Mac-I 
(molecules~turk) x  10 .4  nmol/mg/ 60 rain 
BCG-PM  34 + 4  8 ± 3  23 + 5  50 +  10  ND* 
TPM  91+29  73+ l0  8+2  90+22  65_.  10 
RPM  77+7  60+24  7:t:2  77+11  12+3 
BCG Lyc + PPD: RPM~c  29 ±  7  39 +  14  16 +  1  72 + 4  ND 
BCG Lye + PPD TPM  36 + 8  45 ± 6  23 +- 4  79 + 20  ND 
Lymphokine: RPM~  26 ± 3  40 ±  15  15 +_ 1  80 ±  10  55 + 6 
Lymphokine: TPM  34 ± 6  55 +_ 6  23 ± 3  72 + 6  124 ±  12 
* Not done. 
:~ Adherent m~ from uninfected mice were incubated with BCG-primed lymphocytes (ratio  1:1) plus 50 
#g  PPD,  with  lymphokine  (10% vol/vol)  or with  control  medium  for 2 d  before  assay, except  for 
superoxide release, which was measured after 1 d. 
induced  several of the  parameters of m~  activation  in  vitro, and  that  resident  and 
thioglycollate-elicited m~ provided similar targets. The combination of lymphocytes 
and  PPD  induced  a  two-  to  threefold  increase  in  Ia  and  a  60-70%  decrease  in 
mannose-receptor activity. Ag F4/80  was  again  diminished  to  a  lesser extent  than 
after infection in vivo (35% vs. 85%), whereas mac-1  levels remained unaltered.  PPD 
by itself retained some ability to induce Ia and decrease mannose-specific endocytosis 
in  vitro,  but  the  effect  was  variable  and  less  marked  than  after  intraperitoneal 
injection. Sensitized lymphocytes alone had no effect (not shown). 
Other experiments (not shown)  indicated that BCG-primed lymphocytes and PPD 
induced  fibrinolysis  by  RPM,  as  reported  previously  (2).  The  optimal  ratio  of 
sensitized  lymphocytes to  adherent  mq~  was  1  ×  10S:l  ×  105. A  ratio  >1:1  in  the 
presence of PPD was often cytotoxic to the macrophage target. PPD was effective in 
the concentration range of 25-50 #g/ml;  50/~g/ml was used routinely. 
Role of Lymphokines.  Addition of lymphokine-rich supernatants  to cultivated PM 
induces spreading, secretion of PA (2, 22), the capacity to release H202 (10), enhanced 
Ia expression (7-9), and the ability to kill intracellular organisms (23)  and tumor cell 
targets (24). Lymphokine was prepared by stimulating BCG-primed spleen cells with 
PPD  and added to RPM  and TPM  for different periods of time before assay of m~ 
markers (Table II). These lymphokines were able to enhance Ia two- to threefold, and 
MFR  activity was  reduced  by two-thirds in  both  targets.  Ag F4/80  again  fell to  a 
lesser extent,  by one-third, whereas Mac-1  levels remained unchanged.  Lymphokine 
controls with  PPD  showed <20%  of the efficacy of active supernatants  (not shown). 
Although lymphokines induced similar antigenic and endocytic changes in TPM  and 
RPM,  TPM  secreted twice as much  02- when  challenged with  PMA  subsequently. 
Con  A-induced lymphokines gave similar results to immune  lymphokine.  However, 
some batches contained inhibitory activity(ies) that was nondialyzable, but removable 
by concentration across a  PM-10 membrane. 
Kinetics  and Stability.  The  time course of altered antigen  and  receptor expression 
and  its  reversibility are shown  in  Fig.  3,  in  which  TPM  were  exposed  to  immune 
lymphokines  continuously  for  5  or  2  d  before  withdrawal.  Although  lymphokine 
stimulation affected several markers coordinately, the rate of change for each differed EZEKOWITZ  AND  GORDON  1629 
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FIG. 2.  Mq~ properties after co-cultivation with BCG-primed lymphocytes (L) and PPD.  (A, B) 
Ag. 1 X 105 RPM or TPM were co-cuhivated with  1 X 105 sensitized lymphocytes and 50/~g PPD 
for 48  h,  washed,  fixed in  glutaraldehyde,  and  assayed as  in  Fig.  1.  Pooled  results  of three 
experiments, expressed as percentage change of control (see Table II), mean + SD. (C, D) Mannose- 
specific endocytosis by 5 ×  105 RPM or TPM. 
substantially.  Reduction  of MFR  activity could  be  detected  4  h  after  exposure  to 
lymphokine  and  decreased  progressively until  a  plateau  level  of ~30%  of control 
activity  was  attained  after  1  d.  Reduction  in  F4/80  was  more  gradual  and  less 
extensive, to 70% of control values. Induction ofIa Ag showed a lag period of 1 d  and 
reached a  maximum at day 3. These changes depended upon daily addition of fresh 
lymphokine, and after its removal Ia levels returned towards control values. Recovery 
of MFR  activity and  F4/80 was  incomplete compared with control TPM  in which 
receptor and  Ag levels increased with  cultivation.  This  was  not  due  to cell  loss or 
diminished viability. 
For comparison,  m~ activated in  vivo by infection  were  examined  under  similar 
conditions in culture. Enhanced  Ia expression was stable for 2-3 d  and was then lost 
by day 5  (not shown).  The addition of lymphokine on  day 3,  or  daily addition of 
lymphokine from first plating, failed to reverse this fall, as did addition of PPD, even 1630  LYMPHOCYTE  PRODUCTS  AND THE MACROPHAGE PLASMA MEMBRANE 
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FtG. 3  Activation of TPM by Ag-induced lymphokine. Time course and stability of altered 
expression of Ag  and  MFR  by  lymphokine-activated macrophages. TPM  were treated  with 
lymphokine continuously by daily addition of 10% vol/vol, or for 2 d before washout. Surface Ag 
and specific uptake of ]25I-mannose  BSA were measured as in Fig. 1. Results of replicate assays 
(range <10%) are shown as a percentage of those for untreated TPM cultivated and refed with 
control medium for the same period in culture. Prolonged treatment with lymphokine (--); removal 
of lymphokine (- - -). Control values for TPM cultivated for 4 h, 1, 2, 3, 4, and 5 d, respectively: 
Ag (number of sites/m~b X 10  -4) F4/80 (O): 36, 71, 73, I00, I20, 111; 0X 6 (0): 8, 9, 7, 6, 7; Mac- 
1 ([~): 60, 61, 90, 120, 140, 130; MFR (ng/5 × 10  -5 m~b ) (A): 90, 93, 91, 83, 86, 90. SD is not shown, 
<20% in all cases. 
in the presence of BCG-sensitized lymphocytes. MFR and Ag F4/80 remained low for 
several days and then recovered to 40-50% of the values of untreated TPM after 5 d 
in culture. There was no obvious cell loss and lysozyme poduction, as an index of cell 
viability, was comparable to that of populations that had been cultivated for 2 d. 
Single-cell  Analysis.  Lymphokine-treated m~b were  examined by autoradiography 
to establish whether the altered expression of surface markers was uniform within the 
population.  Ia  Ag  induction was  heterogeneous  (60%  of TPM  and  40%  of RPM 
heavily labeled by 0X 6), but the reduction in MFR activity and F4/80 reflected a 
generalized  decrease  in  all  cells  (>90%  of mq~  labeled,  though  less  heavily  than 
untreated controls), rather than a  subpopulation of unlabeled cells. 
Role  of T  Lymphocytes; Depletion  of Thy-l-positive  Cells.  Table  III  shows  that  the 
alteration of m~ Ag and  MFR  activity by BCG-sensitized lymphocytes and  PPD 
depends on Thy-1 positive cells. After ablation with anti-Thy-1 Ab and complement, 
but not complement alone, mq~ targets retained high levels of MFR and F4/80, and 
showed no increase in Ia Ag when co-cultivated with surviving lymphocytes and PPD. 
Nude Mice.  The properties of BCG-PM obtained from infected CBA nu/nu  mice 
were compared with RPM and TPM from similar animals. Table IV shows that BCG EZEKOWITZ  AND  GORDON  1631 
TABLE  III 
Alteration of Macrophage Surface Markers by BCG-sensitized  Lymphocytes and PPD Depends on 
Thy- 1 Positive Cells * 
Treatment of lymphocytes 
F4/80 
Antigen expression  MFR (ng uptake/ 
5 ×  105 mff/30 
0X 6  Mac-I  min/37°C) 
(molecules/m¢~) X  104 
Anti-Thy-1  + C'  83 ±  10  8 ±  1  90 ±  5  72 ±  8 
C'  37±  15  13±2  93±2  46±6 
none  40±6  18±4  88±6  38±  10 
* B(3G-primed  lymphocytes were treated with anti-Thy-1 plus complement (C') or C' alone, as described, 
and then incubated with TPM plus 50 #g PPD for 48 h before assay. Results of one experiment done in 
triplicate representative of three independent experiments. Mean ±  SD. 
TABLE  IV 
Macrophages from Nude Mice Infected with BCG Express Activation Phenotype * 
Treatment 
MFR (ng up-  Antigen expression  PA (percent 
take/5 ×  10  -5  Superoxide:[:  fibrinolysis/ 
m~p/30 min/  180 min/ 
370(3)  F4/80  0X 6  Mac-I  2 X  10  ~ m~) 
(molecules/m#)  X  10 -4  nmol/mg/ 
60 rain 
BCG-PMnu/nu  27±4  8±2  1l±2  55±2  172±7  65±3 
RPMnu/nu  80±6  46+4  2±2  80±  15  80±40  10±6 
TPMnu/nu  68± 7  27±5  5±2  68±20  33± 7  68±7 
* Macrophages from CBA nude mice (three mice pooled per group)  harvested 8 d after intraperitoneal 
infected with BCG or 4 d  after thioglycollate  injection were plated and assayed  after 4 h.  Results of 
triplicate assays except for PA, which was performed in duplicate. 
TABLE  V 
Effects of Corynebacterium parvum and Other Agents on Macrophage Properties  * 
Treatment 
MFR (rig up-  Antigen expression  PA (percent  fi- 
take/5 X 10  -5  brinolysis/ 
m#/30 rain/  Superoxide  180 min/ 
37oc)  F4/80  0X 6  Mac-I  2 X 10  ~ mq,) 
(molecules/m4~) X  10  -~  nmol/mg/ 
60 min 
C. parvum  24 ±  3  4 ±  2  18 ±  3  36 ±  10  126 ±  12  62 ±  8 
LPS  62 + 8  42 ±  5  6 ±  3  81 ±  5  49 ±  5  18 ±  5 
MDP  40±  15  62±  10  15±3  80±  12  80±  1  16+4 
Proteose peptone  76 ±  12  45 ±  12  9 ±  3  70 ±  20  50 ±  24  22 ±  6 
* Cells adhered for 4 h, washed and assayed. 0.2 ml C parvum was injected intraperitonealty t4 d before 
harvest;  30/zg of LPS, 200 #g of MDP, and 1 ml of/% proteose peptone were injected intraperitoneally 
4 d before harvest. Representative of three independent experiments. Mean +  SD. 
infection  of  nude  mice  reproduced  all  the  changes  associated  with  activation  in 
normal  mice.  TPM  from  nudes resembled their normal  counterparts, as  did  RPM 
from nudes, except for an exceptionally high level of 02-  release in the latter. Similar 
results were obtained  in  three separate experiments and  established that  the mt  h  of 
nude animals are readily activatable according to the present criteria. 1632  LYMPHOCYTE PRODUCTS AND THE MACROPHAGE PLASMA MEMBRANE 
Other stimuli 
C. PA~VUM.  Macrophages obtained after injection of C. parvum resemble BCG-PM 
in their ability to secrete H2Oz, PA, and their tumoricidal and antimicrobial proper- 
ties. 4-h-adherent PM from C. parvum-injected animals have similar surface, endocytic, 
and secretory properties to BCG-PM (Table V). These changes were seen 2-14 d after 
intraperitoneal  injection.  However, an in vitro pulse of C. parvum to a  4-h adherent 
monolayer of RPM  failed to induce the surface changes seen after in vivo injection. 
Phase-contrast  microscopy of cover slip  preparations  confirmed  that  the  mff had 
phagocytised organisms. 
Ir~FLAMMATORV AGENTS.  The  effects  of  intraperitoneal  injection  of  endotoxin, 
proteose peptone, and MDP were also studied. Table V  shows that MDP-elicited m~b 
display properties that are intermediate between RPM and BCG-PM, in that there 
is induction of Ia expression, some decrease in MFR activity (50% of RPM), and, as 
reported by others (25), enhanced secretion of superoxide, whereas fibrinolytic activity 
was  not  increased.  Endotoxin-  and  proteose  peptone-elicited  PM,  however,  were 
similar to RPM. Addition of MDP or LPS in vitro to 4-h-adherent RPM, and further 
cultivation  for 24  or 48  h,  failed  to  induce  any change  in  macrophage surface  or 
secretory  properties.  Although  not  exhaustive,  these  studies  confirmed  that  the 
activation phenotype described was not unique  to BCG infection,  but was confined 
to  agents  such  as  BCG  and  C.  parvum, with  known  ability  to  induce  enhanced 
antimicrobial/cytocidal activity. 
Discussion 
These,  and  earlier  (1)  studies,  establish  that  BCG-activated mouse  macrophages 
display complex changes in surface and endocytic function that accompany enhanced 
secretion  of  reactive  intermediates  of oxygen  and  PA.  Some  plasma  membrane 
antigens  (e.g.,  Ia)  are  increased  in  number,  other  receptors  (MFR,  FcR)  and  Ag 
(F4/80)  are reduced, whereas Mac-1 Ag levels show less consistent change. We show 
further  that  (a)  this  phenotype is  not  unique  to BCG but  can also be induced  by 
another m~b-activating agent, C. parvum. Macrophages elicited by thioglycollate broth, 
LPS, or proteose peptone do not display these changes in Ia, MFR, or F4/80, which 
therefore  discriminate  between  activated  and  nonactivated  cells;  (b)  all  changes 
characteristic  of m4~ activation  by BCG  can  be shown  to  depend  on  sensitized  T 
lymphocytes and specific antigen. However, studies with nude mice indicate that the 
activation phenotype may also arise by an independent pathway; and (c) the altered 
surface properties are stable, occur in a coordinate manner, independent of a particular 
agent, and can be induced in vivo and in vitro. These studies confirm the central role 
of lymphocyte products as extrinsic regulators of mff activation. Down-regulation of 
the MFR, in particular, provides an attractive new marker to study heterogeneity of 
lymphokines and the mechanism of m~b activation. 
Others  have also  reported  changes  in  Ia antigens  (7-9),  lactoperoxidase-labeled 
surface  proteins  (26),  and  of  ectoenzymes  such  as  5'  nucleotidase  and  alkaline 
phosphodiesterase (27)  in BCG and lymphokine-activated macrophages. The plasma 
membrane of the mq~ therefore undergoes extensive, but highly selective remodeling 
upon  activation.  It  is  not  known  if lipids  (28)  and  carbohydrate  constituents  are 
modified to a similar extent. 
Although  the  various  markers  changed  expression  coordinately,  differences  in EZEKOWITZ AND GORDON  1633 
extent, kinetics, and reversibility were noted under various conditions. Intact micro- 
organisms, e.g., BCG, C. Parvum, and, in other studies, Listeria monocytogenes (29), are 
efficient activating agents, but phagocytosis of these agents per se does not provide a 
sufficient stimulus.  Soluble constituents derived from mycobacteria, e.g., MDP and 
PPD, were less effective by themselves, perhaps because of diffusion or more ready 
degradation within the animal. Partial activation observed with PPD in the absence 
of specifically sensitized T lymphocytes could be due to a direct effect on macrophages 
or via  stimulation  of residual  B  lymphocytes  (30).  LPS  does not  bring  about  the 
surface changes characteristic of BCG activation in vivo or in vitro, although it is able 
to  stimulate  other  mq~  functions.  Phagocytosis  of latex  particles  by  LPS-primed 
macrophages, a  procedure designed to enhance their fibrinolytic activity (31), does 
not  induce the  surface properties characteristic of activation  (R.  A.  B.  Ezekowitz, 
unpublished observation). 
T  lymphocytes play an  important  role  in  cellular  immunity  to  BCG  (32)  and 
Listeria  (12),  and  have been implicated  in  the activation of m~b by C. parvum (33). 
Evidence  that  Ag-stimulated  T  lymphocytes influence  the  surface  and  endocytic 
properties of mq~, as well as their secretory activity, was obtained by adoptive transfer 
experiments in vivo and in vitro and by depletion of Thy-1-positive cells with specific 
Ab  and  complement.  These studies  made  it  possible  to compare the  efficiency of 
activation by infection and by lymphocytes and Ag. Reduction in mannose-specific 
endocytosis was  marked  in  all  situations,  whereas  Ag  F4/80  decreased to  a  lesser 
extent  during  activation  by adoptive  transfer  in  vivo or  in  vitro,  compared  with 
infection  in  the  animal.  Such  differences  in  marker  expression  could  be  due  to 
heterogeneity in the mff population induced by different treatments or to additional 
pathways  for activation during infection. Activation in culture represents a  closed 
system, and similar surface changes were observed whether TPM or RPM were used 
as targets. However, during infection newly recruited mff contribute to the activated 
cell  population  (34),  and  it  is  known  that  less  mature  m~b  express  lower levels of 
surface markers such as Ag F4/80 (35). 
The present  studies with  nude mice indicate that  m4,  may also  be activated by 
pathways  independent  of mature T  lymphocytes, although  residual  T  lymphocyte 
function cannot be completely excluded (36). Macrophages from nude animals are 
able  to display some of the  parameters of activation  (37-39),  but  it has  also been 
reported (29) that mff Ia is not induced in nude mice infected with Listeria. Activation 
of complement could contribute to mff activation by C. parvum and other microorga- 
nisms in nude and normal mice (40). 
Lymphokines obtained after Ag or mitogen stimulation were able to modulate all 
activation  markers  in  peritoneal  mq~  from  uninfected  animals.  These effects were 
specific for lymphokines and  have not been observed with LPS-, PMA-,  or L  cell- 
conditioned medium, a source of macrophage colony-stimulating factor (unpublished 
observation). Crude lymphokine preparatiods contain inhibitors as well as stimulatory 
activities,  and  it  will  be  important  to  characterize the  active  mediator(s)  and  its 
mechanism of action. The MFR provides a  sensitive, quantitative, and cell-specific 
marker for such purposes (41). 
Mq~ surface changes initiated by lymphokine vary in their stability. Ia Ag is readily 
lost  upon  removal  of lymphokine,  but  recovery of reduced  receptors  and  surface 
antigens  is  incomplete. Similar results were obtained after cultivation of BCG-PM 1634  LYMPHOCYTE  PRODUCTS  AND  THE  MACROPHAGE  PLASMA MEMBRANE 
from infected mice. The role of sensitized lymphocytes and of specific Ag in main- 
taining the activated state in  vitro should be examined further.  In  our experience, 
BCG-PM become refractory to restimulation  by lymphocytes, Ag, or lymphokines, 
unlike reports on reinduction of Ia Ag on m~, from Listeria-infected  mice (42). 
The  mechanisms  by  which  lymphocyte  products  alter  m~b  properties  are  not 
understood. Decreased endocytosis via mannosyl receptors is associated with reduced 
expression of receptors at the cell surface (1). Down-regulation of MFR by lymphokine 
is rapid, time 1/2 ~ 16 h, independent of known specific ligands, and reaches a plateau 
level, ~25% of control, within 1 d. Residual activity remains stable subsequently and 
is not due to a lymphokine resistant subpopulation. Loss of receptors could be due to 
decreased synthesis and/or increased turnover or shedding, until a  new steady state 
is attained. Other workers have shown that different m~b plasma membrane constit- 
uents vary in their rate of turnover, time 1/2 =  2 to >80 h  (43-46), depending on m4, 
stimulation, interaction with specific ligands, and molecular size.  Differences in the 
kinetics of loss of mannosyl receptors and Ag F4/80 and of induction of Ia Ag are 
compatible with a  common mechanism, e.g., one by which lymphokines selectively 
activate or repress a number of mff gene products. 
Although activated m4~ express reduced levels of MFR  and  FcR compared with 
elicited or resident mff, and endocytosis via these receptors is reduced, the receptors 
remain  functional at  the  cell surface.  The  FoR  mediates extracellular lysis of Ab- 
coated  target  cells  by  stimulating  release  of H202  (47),  and  the  MFR  effectively 
triggers the respiratory burst upon contact with zymosan particles that have not been 
opsonized  (G. Berton, unpublished observation). Whereas both BCG-activated and 
thioglycollate-elicited m~ readily release Oz- after treatment with PMA, more selec- 
tive surface stimuli trigger only the activated cells (G. Berton, unpublished observa- 
tion). These observations indicate that alterations in plasma membrane structure and 
function plays a crucial role in controlling the effector mechanisms of the activated 
mdp. 
Summary 
Bacillus Calmette-Gufirin (BCG)  infection alters the surface and endocytic prop- 
erties of mouse peritoneal macrophages  (PM) compared with thioglycollate-elicited 
(TPM)  or resident  PM  (RPM).  Expression of Ia  antigen  (Ag)  is  enhanced  up  to 
fourfold,  but  plasma  membrane  receptors  that  mediate  binding  and  uptake  of 
mannosyl/fucosyl-terminated glycoconjugates (MFR), Fc receptors, and the macro- 
phage  (mq~)-specific  Ag  F4/80  are  reduced  by  50-80%.  Levels  of Mac-1  remain 
relatively stable. These changes are accompanied by enhanced secretion of O2-, after 
further stimulation  with  phorbyl  myristate acetate,  and  of plasminogen  activator. 
Both these products are released by TPM, but not RPM. The characteristic surface 
phenotype of BCG-PM can also be induced by injection of C. parvum, another mq~- 
activating  agent,  but  not  by  thioglycollxte broth,  lipopolysaccharide,  or  proteose 
peptone. Purified protein derivative (PPD)  and N-acetylmuramyl-L-alanyl-D-isoglu- 
tamine. 2H20 are soluble agents with partial activity. 
Alteration of m~b markers by BCG infection depends on T  lymphocyte function, 
although  studies  with  nude  mice  indicate  that  other  pathways  may also  serve  to 
modify the surface of the m~b. M4~ from uninfected animals displayed all markers of 
activation  after adoptive  transfer of specifically-sensitised lymphocytes with  PPD, EZEKOWITZ AND GORDON  1635 
intraperitoneally, or after co-cultivation. Treatment of primed lymphocytes with anti- 
Thy-1 antibody and complement ablated this effect. Lymphokines obtaned by Ag or 
mitogen stimulation  induced  similar changes in TPM  and RPM.  Mannose-specific 
endocytosis decayed rapidly, time 1/2 -16 h and stabilized at ~25% of control values. 
Single-cell  analysis  showed  that  residual  MFR  activity was  uniform  in  the  target 
population.  Loss  of Ag  F4/80  after  activation  by  lymphocyte  and  PPD  was  less 
marked than after infection (35% vs 80%), unlike MFR activity, which declined to a 
similar extent. Induction of m~ Ia by lymphokine reached a peak after 2-3 d and was 
lost within  2 d  of its removal. Recovery of MFR  and F4/80  was incomplete under 
these conditions. 
These studies establish that activated m4~ known to display enhanced antimicrobial/ 
anticellular activity express markedly different surface properties distinct from elicited 
or  resident  cells.  The  role  of antigen-stimulated  T  cell  products  in  regulating  mq~ 
function  is confirmed, and down-regulation of mannosyl-receptor-mediated endocy- 
tosis  provides  a  sensitive,  quantitative,  and  cell-specific new  marker to study their 
properties and mechanism of action. Extensive, but selective remodeling of m~ plasma 
membrane  structure  could  play  an  important  role  in  controlling  recognition  and 
effector mechanisms of the activated mq~. 
We thank Ms. Maxine Bampton for excellent  technical help. 
Received  for publication 20January 1982  and in revised  form 22 February 1982. 
References 
1.  Ezekowitz,  R. A. B., J. Austyn, P.  D. Stahl, and S. Gordon.  1981. Surface properties of 
bacillus Calmette-Gu6rin-activated mouse macrophages. Reduced expression  of mannose- 
specific endocytosis,  Fc receptors, and antigen F4/80 accompanies induction of Ia. J. Exp. 
Med. 154:60. 
2.  Gordon,  S.,  and  Z.  A.  Cohn.  1978. Bacille  Calmette  Gu6rin  infection  in  the  mouse. 
Regulation of macrophage plasminogen activator by T lymphocytes and specific antigen. 
J. Exp. Med. 147:1175. 
3. Johnston,  R.  B. Jr.,  C.  A.  Godzik, and  Z.  A.  Cohn.  1978. Increased superoxide anion 
production  by immunologically activated and  chemically elicited  macrophages. J. Exp. 
Med. 148:115. 
4.  Nathan, C. F., and R. K. Root.  1977. Hydrogen peroxide release  from mouse peritoneal 
macrophages. Dependance on sequential activation and triggering. J. Exp. Med. 146:1648. 
5.  Hibbs, J. B.  1975. Activated macrophages as cytotoxic effector cells. Transplantation (Balti- 
more). 19:77. 
6.  Freedman, V. H., T. A. Calvelli, S. Silagi, and S. C. Silverstein.  1980. Macrophages elicited 
with  heat-killed  bacillus  Calmette-Gu6rin  protect  C57BL/6J  mice against  a  syngeneic 
melanoma.]. Exp. Med. 152:657. 
7.  Steinman, R. M., N. Nogueira, M. D. Witmer, J. D. Tydings, and I. S. Mellman.  1980. 
Lymphokine enhances  the  expression  and  synthesis  of Ia antigens  on  cultured  mouse 
peritoneal macrophages. J. Exp. Med. 152:1248. 
8.  Steeg, P. S., R. N. Moore, and J. J. Oppenheim. 1980. Regulation of murine macrophage 
la-antigen expression  by products of activated spleen cells. J. Exp. Med. 152:1734. 
9.  Scher, M., D. I. Belier, and E. R. Unanue.  1980. Demonstration of a soluble mediator that 
induces  exudates rich in Ia-positive macrophages.J. Exp. Med. 152:1684. 
10.  Nathan, C., N. Nogueira, C. Juangbhanich, J. Ellis, and Z. A. Cohn.  1979. Activation of 1636  LYMPHOCYTE  PRODUCTS  AND  THE  MACROPHAGE  PLASMA  MEMBRANE 
macrophages in vivo and in vitro. Correlation between hydrogen peroxide release and killing 
of Trypanosoma cruzi. J. Exp. Med.  149;1056. 
11.  North, R.J.  1973. Importance of thymus-derived lymphocytes in cell-mediated immunity 
of infection. Cell. Immunol. 7:166. 
12.  Lane,  F.  C.,  and  E.  R.  Unanue.  1972. Requirement  of thymus  (T)  lymphocytes  for 
resistance to listeriosis.J. Exp. Med.  135:1104. 
13.  McMaster, W. R., and A. F. Williams. 1979. Monoclonal antibodies to Ia antigens from 
rat  thymus:  cross  reactions with  mouse  and  human  and  use  in  purification of rat  Ia 
glycoproteins. Immunol. Rev. 47:117. 
14.  Austyn, J.  A., and  S. Gordon.  1981. F4/80, a  monoclonal antibody directed specifically 
against the mouse macrophage. Eur. J. Immunol. 11:805. 
15.  Unkeless, J.  C.  1979. Characterization of monoclonal  antibody directed against mouse 
macrophage and lymphocyte Fc receptors.J. Exp. Med.  150:580. 
16.  Springer,  T.,  G.  Galfre,  D.  S.  Secher,  and  C.  Milstein.  1979. Mac-I:  a  macrophage 
differentiation antigen identified by monoclonal antibody. Eur. J. Immunol. 9:301. 
17.  Lowry, D. H., N. J. Rosebrough, A. L. Farr, and R. J. Randall, 1951. Protein measurement 
with folin phenol reagent. J. Biol. Chem. 193:265. 
18.  Julius, M. H., E. Simpson, and L. A. Herzenberg.  1973. A rapid method for the isolation 
of functional thymus-derived murine lymphocytes. Eur. J. Immunol. 3:645. 
19.  Lafferty, K. J., L. Andrus, and S. J. Prowse.  1980. The role of lymphokine and antigen in 
the control of specific T  cell responses. Immunol. Rev. 51:279. 
20.  Gordon, S.  1978. Assays for macrophage activation and secretion products. In Handbook 
of Experimental Immunology. 3rd edition. D. M. Weir, editor. Blackwell Scientific Publi- 
cations, Oxford. 33:1-14. 
21.  Babior, B. M., R. S. Kipnes, and J. T. Curnutte.  1978. Biological defense mechanisms. The 
production by leukocytes of superoxide, a potent bactericidal agent. J. Clin. Invest. 56:1035. 
22.  Nogueira, M.,  S.  Gordon, and  Z.  Cohn.  1977. Trypanosoma cruzi:  the  immunological 
induction of macrophage plasminogen activator requires Thymus-derived lymphocytes. J. 
Exp. Med.  146:172. 
23.  Sharma,  S.  D.,  and J.  S.  Remington.  1981. Macrophage  activation and  resistance  to 
intracellular infection. Lymphokines. 3:181. 
24.  Meltzer, M. S. 1981. Tumor cytotoxicity by lymphokine-activated macrophages: develop- 
ment  of macrophage tumoricidal activity requires a  sequence of reactions. Lymphokines. 
3:319. 
25.  Cummings, N. P., M. J. Pabst, and R. B. Johnston, Jr.  1980. Activation of macrophages 
for enhanced release of superoxide anion and greater killing of Candida albicans by injection 
of muramyl dipeptide.J. Exp. Med.  152:1659. 
26.  Yin,  H., S. Aley, C.  Bianco, and Z. A. Cohn.  1980. Plasma membrane polypeptides of 
resident and activated mouse peritoneal macrophages. Proc. Natl. Acad. Sci. U. S. A. 77:2188. 
27.  Morahan, P. S., P. J.  Edelson, and K. Gass.  1980. Changes in macrophages ectoenzymes 
associated with anti-tumor activity.  J. lmmunol. 125:1312. 
28.  Mahoney, E. M., W. A. Scott, F. R.  Landsberger, A. L. Hamill, and Z. A. Cohn.  1980. 
Influence  of fatty  acyl  substitution  on  the  composition  and  function  of macrophage 
membranes.J. Biol. Chem. 255:4910. 
29.  Lu, C. Y., E. Peters, and E. R. Unanue.  1981. Ia bearing macrophages in athymic mice: 
antigen presentation and regulation. J. lmmunol. 126:2496. 
30.  Sultzer, B.  M.,  and  K.  Nilsson.  1972. PPD  tuberculin-a B  cell mitogen.  Nat.  New  Biol. 
240:198. 
31.  Gordon, S., Unkeless, J. C. and Cohn, Z. A. 1974. Induction of macrophage plasminogen 
activator by endotoxin stimulation and phagocytosis. Evidence for a two-stage process. J. 
Exp. Med. 140:995. EZEKOWITZ AND GORDON  1637 
32.  Lefford, M. J.  1975. Transfer of adoptive immunity to tuberculosis in mice. Infect. Immun. 
7:1174. 
33.  Sljivic, V. S., and S. R. Watson. 1977. The adjuvant effect of Co~ynebacterium parvum: T-cell 
dependence of macrophage activation.J. Exp. Med. 145:45. 
34.  Spector, W. G., and G. B.  Ryan.  1970. The mononuclear phagocyte in inflammation. In 
Mononuclear Phagocytes. R. van Furth, editor. Blaekwell Scientific Publications, Oxford. 
219. 
35.  Hirsch,  S., J.  M.  Austyn, and  S.  Gordon.  1981. Expression of the macrophage-specific 
antigen F4/80 during differentiation of mouse bone marrow cells in cultureJ. Exp.  Med. 
154:713. 
36.  H/inig, T., and M. J.  Bevan.  1980. Specificity of cytotoxic T  cells from athymic mice. J. 
Exp. Med. 152:688. 
37.  Cheers, C., and R. Waller.  1975. Activated macrophages in congenitally athymic 'nude' 
mice and in lethally irradiated mice. J. Immunol. 115:844. 
38.  Cutler, J. E., and H. H. Poor. 1981. Effect of mouse phagocytes on Candida albicans in in vivo 
chambers. Infect. Immun. 31:1110. 
39.  Johnson, W. J., and E. Balish.  1980. Maerophage function in germ-free, athymic (nu/nu) 
and conventional flora (nu/  + ) mice. Res. J. Reticuloendothel. Soc. 28:55. 
40.  Ghaffar, A. 1980. The activation of macrophages by Corynebacterium  parvum: effects of anti- 
complementary agents cobra venom factor and sodium cyanate. Res. J. Reticuloendothel. Soc. 
27:327. 
41.  Stahl, P., and S. Gordon. 1982. Expression of a mannosyl-fucosyl receptor for endocytosis 
on cultured primary macrophages and their hybrids. J. Cell Biol. 93:49. 
42.  Belier, D. I., and E. R. Unanue.  1981. Regulation of macrophage Ia antigen expression. In 
Naito Symposium on Self Defence Mechanisms, Tokyo. Role of Macrophages. In press. 
43.  Edelson, P. J.,  and  Z. A. Cohn.  1976. Nucleotidase activity of mouse peritoneal macro- 
phages.  I  Synthesis and  degradation in  resident and  inflammatory populations. J.  Exp. 
Med. 144:1581. 
44.  Werb, Z., and Z. A. Cohn. 1972. Plasma membrane synthesis in the maerophage following 
phagocytosis of polystyrene latex particles.  J. Biol. Chem. 247:2439. 
45.  Mellman, J., J. C. Unkeless, R. Steinman, and Z. A. Cohn.  1981. Internalization and fate 
of Fc receptors during endocytosis.J. Cell Biol. 91:124a. 
46.  Kaplan, G., J. C. Unkeless, and Z. A. Cohn.  1979. Insertion and turnover of macrophage 
plasma membrane proteins. Proc. Natl. Acad. Sci. U. S. A. 76:3824. 
47.  Nathan, C., L. Bruckner, G. Kaplan, J.  Unkeless, and Z. Cohn.  1980. Role of activated 
macrophages in antibody-dependent lysis of tumor cells. J. Exp. Med. 152:183. 